Z-0516-2024 Class II Ongoing

Recalled by BioReference Health, LLC — Elmwood Park, NJ

FDA device recall Z-0516-2024 was initiated by BioReference Health, LLC on Oct 31, 2023 and is designated Class II. Reason for recall: Mathematical modeling of the 4Kscore with and without DRE information was recently performed on over 3,000 specimens. DRE information is a required component of The 4Kscore Test. The recall status is ongoing. Affected quantity: 1 system (3,196 tests).

Recall details

Product Type
Devices
Report Date
Dec 20, 2023
Initiation Date
Oct 31, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 system (3,196 tests)

Product description

The 4Kscore Test, an in vitro serum or plasma test that combines the results of four immunoassays (Roche Elecsys total PSA (prostate specific antigen), Roche Elecsys free PSA, intact PSA, and human kallikrein 2) into a single numerical score that also incorporates the following information: a patient s age, previous biopsy, and digital rectal exam (DRE).

Reason for recall

Mathematical modeling of the 4Kscore with and without DRE information was recently performed on over 3,000 specimens. DRE information is a required component of The 4Kscore Test.

Distribution pattern

US Nationwide distribution.

Code information

UDI-DI: 00850038860004

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0516-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0516-2024. Report a data issue: hello@regdatalab.com.